Marginal note: Prohibition — clinical trials
3.1 No person shall conduct a clinical trial in respect of a drug, device or prescribed food for a special dietary purpose unless the person holds an authorization issued under the regulations that authorizes the conduct of the clinical trial.
Marginal note: Terms and conditions — clinical trial authorizations
3.2 The holder of an authorization referred to in section 3.1 shall comply with any terms and conditions of the authorization that are imposed by the Minister under regulations made under paragraph 30(1)(b.3).
Marginal note: Duty to publicize clinical trial information
3.3 The holder of an authorization referred to in section 3.1 shall ensure that prescribed information concerning the clinical trial is made public within the prescribed time and in the prescribed manner.
Marginal note: Prohibited sales of food
Marginal note: Deception, etc., regarding food
Marginal note: Importation and interprovincial movement of food
any article that is intended for sale and that is likely to be mistaken for that food unless the article complies with the prescribed standard.
in such a manner that it is likely to be mistaken for that food unless the article complies with the prescribed standard.
Marginal note: Governor in Council may identify standard or portion thereof
Marginal note: Unsanitary manufacture, etc., of food
7 No person shall manufacture, prepare, preserve, package or store for sale any food under unsanitary conditions.
Marginal note: Prohibited sales of drugs
8 No person shall sell any drug that
Marginal note: Deception, etc., regarding drugs
Marginal note: Where standard prescribed for drug
Marginal note: Unsanitary manufacture, etc., of drug
11 No person shall manufacture, prepare, preserve, package or store for sale any drug under unsanitary conditions.
Marginal note: Drugs not to be sold unless safe manufacture indicated
12 No person shall sell any drug described in Schedule C or D unless the Minister has, in prescribed form and manner, indicated that the premises in which the drug was manufactured and the process and conditions of manufacture therein are suitable to ensure that the drug will not be unsafe for use.
Marginal note: Drugs not to be sold unless safe batch indicated
13 No person shall sell any drug described in Schedule E unless the Minister has, in prescribed form and manner, indicated that the batch from which the drug was taken is not unsafe for use.
Marginal note: Samples
14 No person shall distribute or cause to be distributed any drug as a sample except in accordance with the regulations.
Marginal note: Schedule F drugs not to be sold
15 No person shall sell any drug described in Schedule F.
Marginal note: Prohibited sales of cosmetics
16 No person shall sell any cosmetic that
Marginal note: Prohibited sales — animal testing
Marginal note: Prohibition — animal testing
16.2 No person shall conduct a test on an animal that could cause pain, suffering or injury, whether physical or mental, to the animal if the purpose of the test is to meet, with respect to a cosmetic, a requirement under a provision of this Act or the regulations or to meet a requirement that relates to the safety of cosmetics under the law that applies in a foreign state.
Marginal note: Prohibited claims — animal testing
Marginal note: Where standard prescribed for cosmetic
17 Where a standard has been prescribed for a cosmetic, no person shall label, package, sell or advertise any article in such a manner that it is likely to be mistaken for that cosmetic, unless the article complies with the prescribed standard.
Marginal note: Unsanitary conditions
18 No person shall manufacture, prepare, preserve, package or store for sale any cosmetic under unsanitary conditions.
Marginal note: Prohibited sales of devices
19 No person shall sell any device that, when used according to directions or under such conditions as are customary or usual, may cause injury to the health of the purchaser or user thereof.
Marginal note: Deception, etc., regarding devices